Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity.
D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002472:Cell Transformation, Viral; D003114:Colony-Forming Units Assay; D004305:Dose-Response Relationship, Drug; D004854:Herpesvirus 4, Human; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology*; D008214:Lymphocytes / Q000166:cytology; D008727:Methotrexate / Q000037:antagonists & inhibitors*; D013936:Thymidine / Q000494:pharmacology*
D007042:Hypoxanthines; D013936:Thymidine; D008727:Methotrexate